Use of 2-methylene-19-nor-(20S)-1α,25-Dihydroxyvitamin D3 to treat and prevent secondary hyperparathyroidism in a subject having renal failure
US-10046000-B2 · Aug 14, 2018 · US
This page is not indexed by search engines while we improve data quality.
Patent family 47997980
This patent family groups 6 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 47997980 |
| Family type | — |
| Earliest priority | Jun 29, 2012 |
| First filing country | US |
| Member publications | 6 |
| Countries | US |
| Representative publication | US10046000B2 — Use of 2-methylene-19-nor-(20S)-1α,25-Dihydroxyvitamin D3 to treat and prevent secondary hyperparathyroidism in a subject having renal failure |
Representative publication
Best representative member for this family based on priority and filing country.
US10046000B2 — Use of 2-methylene-19-nor-(20S)-1α,25-Dihydroxyvitamin D3 to treat and prevent secondary hyperparathyroidism in a subject having renal failure (published Aug 14, 2018)
Member publications
Related publications in this family.
Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism
US-2017252360-A1 · Sep 7, 2017 · US
Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to prevent secondary hyperparathyroidism or the symptoms thereof
US-9717744-B2 · Aug 1, 2017 · US
Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism
US-2016136184-A1 · May 19, 2016 · US
Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism
US-9205096-B2 · Dec 8, 2015 · US
Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism
US-9034853-B2 · May 19, 2015 · US